Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer

被引：0
|
作者：
Sharvina Ziyeh
Lauren Wong
Reva K. Basho
机构：
[1] UCLA Olive View Medical Center,
[2] Cedars-Sinai Medical Center,undefined
[3] The Lawrence J. Ellison Institute for Transformative Medicine,undefined
来源：
Current Oncology Reports | 2023年 / 25卷
关键词：
Hormone receptor-positive breast cancer; HER2 negative breast cancer; Endocrine therapy; CDK4/6 inhibition; PI3K inhibition; AKT inhibition; PIK3CA mutation; SERDs; SERMs; PROTACs; SERCAs; CERANs; SARMs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：689 / 698
页数：9
相关论文
共 50 条
  • [31] Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
    D'Souza, Anishka
    Spicer, Darcy
    Lu, Janice
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [32] RETRACTION: Challenges of combined everolimus/endocrine therapy in hormone receptor-positive metastatic breast cancer
    Porta, Camillo
    ONCOLOGY REVIEWS, 2014, 8 (01) : 6 - 6
  • [33] Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
    Beomyoung Cho
    Maria Pérez
    Donna B. Jeffe
    Matthew W. Kreuter
    Julie A. Margenthaler
    Graham A. Colditz
    Ying Liu
    BMC Cancer, 22
  • [34] What Is the Optimal Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer?
    Tung, Nadine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) : 1391 - 1397
  • [35] Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy
    Nardin, Simone
    Ruelle, Tommaso
    Giannubilo, Irene
    Del Mastro, Lucia
    TUMORI JOURNAL, 2024, 110 (03): : 162 - 167
  • [36] Adjuvant Endocrine Therapy of Perimenopausal and Recently Postmenopausal Women With Hormone Receptor-Positive Breast Cancer
    Pan, Kathy
    Chlebowski, Rowan T.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 147 - 153
  • [37] Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
    Cho, Beomyoung
    Perez, Maria
    Jeffe, Donna B.
    Kreuter, Matthew W.
    Margenthaler, Julie A.
    Colditz, Graham A.
    Liu, Ying
    BMC CANCER, 2022, 22 (01)
  • [38] Chemotherapy combined with endocrine neoadjuvant therapy for hormone receptor-positive local advanced breast cancer: a case report and literature review
    Zhang, Nengying
    Luo, Chengmin
    Li, Jiayang
    Bao, Yuxiang
    Yan, Zhongliang
    Cheng, Xiaoming
    Li, Taolang
    Lv, Junyuan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [39] A randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
    Connolly, Roisin M.
    Zhao, Fengmin
    Miller, Kathy D.
    Tevaarwerk, Amye J.
    Wagner, Lynne I.
    Lee, Min-Jung
    Murray, Judy
    Gray, Robert
    Piekarz, Richard L.
    Zujewski, Jo Anne A.
    Sparano, Joseph A.
    CANCER RESEARCH, 2015, 75
  • [40] Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer
    Yamamoto, Yutaka
    Goto-Yamaguchi, Lisa
    Takeno, Masako
    Yamamoto-Ibusuki, Mutsuko
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03) : 30
12345